4.3. LCC-09 Suppressed the Viability and Metastatic Phenotype of GBM Cells through the Dysregulation of DRD4-Mediated AKT/mTOR and NF-κB Signaling Axes. This evidence concerns the gene DRD4 and glioblastoma.